Nutrition Support of Patients With Enterocutaneous Fistulas

1. Berry SM , Fischer JE . Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am 1996;76:1009–18.

2. Rombeau JL , Rolandelli RH . Enteral and parenteral nutrition in patients with enteric fistulas and short bowel syndrome. Surg Clin North Am 1987;67:551–71.

3. Edmunds LH , Williams GM , Welch CE . External fistulas arising from the gastrointestinal tract. Ann Surg 1960;152:445–71.

4. Berry SM , Fischer JE . Enterocutaneous fistulas. Curr Prob Surg 1994;31:471–564.

5. Rolandelli RH , Roslyn JJ . Surgical management and treatment of sepsis associated with gastrointestinal fistulas. Surg Clin North Am 1996;67:1111–22.

6. Smith DW , Lee RM . Nutritional management in duodenal fistulas. Surg Gynecol Obstet 1956;103:666–72.

7. Bury KD , Stephens RV , Randall HT . Use of a chemically defined, liquid, elemental diet for nutritional management of the alimentary tract. Am J Surg 1971;121:174–83.

8. Voitk AJ , Echave V , Brown RA, et al. Elemental diets in the treatment of fistulas of the alimentary tract. Surg Gynecol Obstet 1973;137:68–72.

9. Rocchio MA , Cha CM , Haas KF, et al. Use of chemically defined diets in the management of patients with high output gastrointestinal fistulas. Am J Surg 1974;127:148–53.

10. Reber HA , Roberts C , Way L, et al. Management of external gastrointestinal fistulas. Ann Surg 1978;188:460–7.

11. Soeters PB , Ebeid AM , Fischer JE . Review of 404 patients with gastrointestinal fistulas. Ann Surg 1979;190:189–202.

12. MacFayden BV , Dudrick SJ , Ruberg RL . Management of gastrointestinal fistulas with parenteral hyperalimentation. Surgery 1973;74:100–5.

13. Ryan JA Jr , Adye BA , Weinstein AJ . Enteric fistulas. In: Rombeau JL , Caldwell MD , eds. Clinical nutrition, vol II, Parenteral nutrition. Philadelphia: WB Saunders, 1986;419–36.

14. Himal HS , Allard JR , Nadea JE, et al. The importance of adequate nutrition in closure of small intestinal fistulas. Br J Surg 1974;61:724–30.

15. Deitel M. Nutritional management of external gastrointestinal fistulas. Can J Surg 1976;19:505–9.

16. Tilson MD . Pathophysiology and treatment of short bowel syndrome. Surg Clin North Am 1980;60:1273–84.

17. Graham JA . Conservative treatment of gastrointestinal fistulas. Surg Gynecol Obstet 1977;144:512–14.

18. Kaminsky MV , Deitel M. Nutritional support in the management of external fistulas of the alimentary tract. Br J Surg 1975;62:100–3.

19. Silberman H , Granson M , Fong G, et al. Management of gastrointestinal fistulas with glucose and lipids. Surg Gynecol Obstet 1980;150:856–8.

20. Aguirre A , Fischer JE , Welch CE . The role of surgery and hyperalimentation in therapy of gastrointestinal-cutaneous fistulae. Ann Surg 1974;180:393–401.

21. Kuvshinoff BW , Brodish RJ , McFadden DW, et al. Serum transferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal cutaneous fistulas. Ann Surg 1993;217:615–23.

22. Rose D , Yarborough MF , Canizaro PC, et al. One hundred and fourteen fistulas of the gastrointestinal tract treated with total parenteral nutrition. Surg Gynecol Obstet 1986;163:345–50.

23. Taranzi R , Coutsoftides T , Steiger E, et al. Gastric and duodenal cutaneous fistulas. World J Surg 1983;7:463.

24. Foster CE III , Lefor AT . General management of gastrointestinal fistulas. Surg Clin North Am 1996;76:1019–33.

25. Jaques P , Mauro M , Safrit H, et al. CT features of intraabdominal abscesses: prediction of successful percutaneous drainage. Am J Roentgenol 1986;146:1041–5.

26. Lambiase RE , Deyoe L , Cronan JJ, et al . Percutaneous drainage of 335 consecutive abscess: results of primary drainage with 1-year follow-up. Radiology 1992;184:167–79.

27. Schecter S , Eisenstat TE , Oliver GC, et al. Computerized tomographic scan-guided drainage of intra-abdominal abscesses. Dis Colon Rectum 1994;37:984–8.

28. Fischer JE . The pathophysiology of enterocutaneous fistulas. World J Surg 1983;7:446–50.

29. McLean GK . Radiologic techniques of gastrointestinal intubation. In: Rombeau JL , Caldwell MD , eds. Clinical nutrition, Vol I. Enteral nutrition. Philadelphia: WB Saunders, 1984;240–52.

30. Levy E , Palmer DL , Frileux P, et al. Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the distal small bowel. A clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg 1983;198:596–600.

31. Levy E , Frileux P , Cugnenc PH, et al. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 1989;76:676–9.

32. DeBiasse MA , Wilmore DW . What is optimal nutritional support? New Horizons 1994;2:122–30.

33. Koruda MJ . Dietary fiber and gastrointestinal disease. Surg Gynecol Obstet 1993;177:209–14.

34. LeLeiko NS , Walsh MJ . The role of glutamine, short-chain fatty acids, and nucleotides in intestinal adaptation to gastrointestinal disease. Ped Clin North Am 1996;43:451–70.

35. Fisher JE . Enterocutaneous fistula. In: Cameron JE , ed. Current surgical therapy, 4th ed. St Louis: Mosby-Year Book, 1992;136–42.

36. Grauer L , Barkin JS . Role of somatostatin and octreotide in the treatment of pancreatic pseudocyst, fistula and ascites. Dig 1994:55 (Suppl 1):24–8.

37. Pederzoli P , Bassi C , Falconi M, et al. Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion on somatostatin, glucagon or calcitonin. Surg Gynecol Obstet 1986;163:428–32.

38. Bauer W , Briner U , Doepfner W, et al. SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982;31:1133–40.

39. Chanson P , Timsit J , Harris AG . Clinical pharmacokinetics of octreotide: therapeutic applications in patients with pituitary tumors. Clin Pharmacokinet 1993;25:375–91.

40. Fuessl HS , Caolan G , Williams G, et al. Effect of a long-acting somatostatin analogue (SMS 201–995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion 1987;36:101–7.

41. Lembcke B , Creutzfeld W , Schleser S, et al. Effects of the somatostatin analogue Sandostatin (SMS 201–995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987;36:108–24.

42. Nubiola-Calonge P , Badia JM , Sancho J, et al. Blind evaluation of the effect of octreotide (SMS 201–995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987;2:672–4.

43. Nubiola P , Badia JM , Martinez-Rodenas F, et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201–995. Ann Surg 1989;210:56–8.

44. Sitges-Serra A , Jaurrita E , Sitges-Creus A. Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg 1982;69:147–50.

45. Zinner MJ , Baker RR , Cameron JL . Pancreatic cutaneous fistulas. Surg Gynecol Obstet 1974;138:710–2.

46. Martineau P , Shwed J , Denis R. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure? Am J Surg 1996;172:386–96.

47. Torres AJ , Landa JI , Moreno-Azcoita M, et al. Somatostatin in the management of gastrointestinal fistulas. Arch Surg 1992;127:97–100.

48. Spiliotis J , Briand D , Gouttebel MC, et al. Treatment of fistulas of the gastrointestinal tract with total parenteral nutrition and octreotide in patients with carcinoma. Surg Gynecol Obstet 1993;176:575–80.

49. Boike GM , Sightler SE , Averette HE . Treatment of small intestinal fistulas with octreotide, a somatostatin analog. J Surg Oncol 1992;49:63–5.

50. Borison DI , Bloom AD , Pritchard TJ . Treatment of enterocutaneous and colcutaneous fistulas with early surgery or somatostatin analog. Dis Colon Rectum 1992;35:635–9.

51. Chen RJ , Fang JF , Chen MF . Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding. Am J Gastroenterol 1992;87:1212–5.

52. Katz MD , Erstad BL . Octreotide, a new somatostatin analogue. Clin Pharm 1989;8:255–73.

53. Sancho JJ , DiCostanzo J , Nubiola P, et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995;82:L638–641.

54. Popovic V , Chayvialle JA , Wass JAH . Proceedings of the discussion: tolerability and safety of Sandostatin. Digestion 1993;54 (Suppl 1):104–6.

55. Dowling RH , Hussaini SH , Murphy GM, et al. Gallstones during octreotide therapy. Digestion 1993;54 (Suppl 1):107–20.

56. Katz MD , Erstad BL . Octreotide, a new somatostatin analogue. Clin Pharm 1989;8:255–73.

57. Kraenzlin ME , Wood SM , Neufeld M, et al. Effect of long-acting somatostatin-analogue, SMS 201–995 on gut hormone secretion in normal subjects. Experientia 1985;41:738–40.